title: Association of angiotensin-converting enzyme gene polymorphism with schizophrenia and depressive symptom severity in a Chinese population.
abstract: BACKGROUND
  Depressive symptoms are frequently observed in schizophrenia patients. Angiotensin-converting enzyme (ACE), a key enzyme of renin-angiotensin system, can catalyze the degradation of neuropeptides and modulate dopaminergic and serotonergic neurotransmission. Previous studies have revealed the association of the ACE gene insertion/deletion polymorphism with depressive disorder and its treatment response but not with the depressive symptoms in schizophrenia.
  
  
  OBJECTIVE
  The aim of this study is to examine whether this polymorphism was associated with susceptibility to schizophrenia and with its psychopathological symptoms, especially depressive symptoms in a Han Chinese population.
  
  
  METHODS
  This polymorphism was genotyped in 382 chronic patients and 538 healthy controls. Psychopathology was characterised using the positive and negative syndrome scale.
  
  
  RESULTS
  The allelic and genotypic frequencies of this polymorphism significantly differed between patients and controls (both p < 0.001). A significant difference in the positive and negative syndrome scale depressive symptom score was observed among the three genotypes (p < 0.03), with higher score in patients with insertion/insertion (I/I) than with deletion/deletion (D/D) genotypes (p < 0.05). Furthermore, there was a significant linear correlation between the number of I alleles and the depressive symptom score (p < 0.05).
  
  
  CONCLUSIONS
  The ACE gene insertion/deletion polymorphism may play a role in susceptibility to schizophrenia and also in its depressive symptom severity in a Han Chinese population.
authors.affiliation: Institute of Kangning Mental Health, Wenzhou Kangning Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.
authors.forename: Li
authors.initials: L
authors.lastname: Hui
authors.forename: Jing Qin
authors.initials: JQ
authors.lastname: Wu
authors.forename: Min Jie
authors.initials: MJ
authors.lastname: Ye
authors.forename: Ke
authors.initials: K
authors.lastname: Zheng
authors.forename: Jin Cai
authors.initials: JC
authors.lastname: He
authors.forename: Xuan
authors.initials: X
authors.lastname: Zhang
authors.forename: Jia Hong
authors.initials: JH
authors.lastname: Liu
authors.forename: Hai Jia
authors.initials: HJ
authors.lastname: Tian
authors.forename: Ben Hong
authors.initials: BH
authors.lastname: Gong
authors.forename: Da Chun
authors.initials: DC
authors.lastname: Chen
authors.forename: Meng Han
authors.initials: MH
authors.lastname: Lv
authors.forename: Jair C
authors.initials: JC
authors.lastname: Soares
authors.forename: Xiang Yang
authors.initials: XY
authors.lastname: Zhang
mesh_terms: D000328:Adult; D000368:Aged; D044466:Asian People / Q000235:genetics; D003863:Depression / Q000235:genetics*; D005260:Female; D005787:Gene Frequency; D056726:Genetic Association Studies; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D005838:Genotype; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D007703:Peptidyl-Dipeptidase A / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide / Q000502:physiology*; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000235:genetics*
chemical_list: D007703:Peptidyl-Dipeptidase A
keywords: angiotensin-converting enzyme; association; chronic and medicated schizophrenia; depressive symptoms; genetic polymorphism; positive and negative syndrome scale